|
|
Other links at Articles > Pathology and Lab Medicine |
| 5. |
First-Line Targeted Therapy for Poor PS NSCLC
|
|
|
Dr. Maurie Markman comments on a study published in the Journal of Clinical Oncology demonstrating the benefit of anti-EGFR therapy in this difficult-to-treat population. Medscape Genomic Medicine
|
|
|